Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30043910HIVENSG00000168610.17protein_codingSTAT3YesNo6774P40763
TVIS30043911HIVENSG00000168610.17protein_codingSTAT3YesNo6774P40763
TVIS30043912HIVENSG00000168610.17protein_codingSTAT3YesNo6774P40763
TVIS30043913HIVENSG00000168610.17protein_codingSTAT3YesNo6774P40763
TVIS30043914HIVENSG00000168610.17protein_codingSTAT3YesNo6774P40763
TVIS30043915HIVENSG00000168610.17protein_codingSTAT3YesNo6774P40763
TVIS30043916HIVENSG00000168610.17protein_codingSTAT3YesNo6774P40763
TVIS30043917HIVENSG00000168610.17protein_codingSTAT3YesNo6774P40763
TVIS30043918HIVENSG00000168610.17protein_codingSTAT3YesNo6774P40763
TVIS30043919HIVENSG00000168610.17protein_codingSTAT3YesNo6774P40763
TCGA Plot Options
Drug Information
GeneSTAT3
DrugBank IDDB16630
Drug NameOPB-111077
Target IDBE0003462
UniProt IDP40763
Regulation Typeinhibitor
PubMed IDs29511132
CitationsTolcher A, Flaherty K, Shapiro GI, Berlin J, Witzig T, Habermann T, Bullock A, Rock E, Elekes A, Lin C, Kostic D, Ohi N, Rasco D, Papadopoulos KP, Patnaik A, Smith L, Cote GM: A First-in-Human Phase I Study of OPB-111077, a Small-Molecule STAT3 and Oxidative Phosphorylation Inhibitor, in Patients with Advanced Cancers. Oncologist. 2018 Jun;23(6):658-e72. doi: 10.1634/theoncologist.2017-0325. Epub 2018 Mar 6.
GroupsInvestigational
Direct Classification
SMILES
Pathways
PharmGKB
ChEMBL